Cough Management in Bronchitis
Primary Treatment Approach for Bronchitis-Related Cough
- The American College of Chest Physicians recommends ipratropium bromide as the preferred initial treatment for improving cough in stable patients with chronic bronchitis, with a Grade A recommendation, reducing cough frequency, cough severity, and volume of sputum expectorated 1, 2, 3
- Short-acting β-agonists should be used to control bronchospasm and relieve dyspnea, with a Grade A recommendation, and may also reduce chronic cough 2, 5, 6
- Standard dosing for ipratropium bromide is 36 μg (2 inhalations) four times daily 3, 4
Role of Adjunctive Therapies
- Benzonatate may be used for short-term symptomatic relief of cough when it is severely affecting quality of life, acting peripherally by anesthetizing stretch receptors in the respiratory passages 8, 9
- The American College of Chest Physicians suggests that while benzonatate can provide relief, it should not be the primary treatment, and bronchodilators, particularly ipratropium bromide, are the evidence-based first-line therapy for cough due to bronchitis 1, 2
Treatment Algorithm
- The treatment algorithm recommends starting with ipratropium bromide 36 μg (2 inhalations) four times daily as primary therapy, with the option to add benzonatate for short-term symptomatic relief if cough is severely affecting quality of life 3, 4, 8
Special Considerations
- Theophylline can improve cough in stable chronic bronchitis with a Grade A recommendation, but concerns about side effects in elderly patients and drug interactions make it a less preferred option 2, 5, 6
- Long-term prophylactic antibiotics are not recommended for stable chronic bronchitis, with a Grade I recommendation 1, 4, 7